Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hospira Inc Issues FY 2013 Guidance; EPS Guidance Below Analysts' Estimates


Wednesday, 13 Feb 2013 07:36am EST 

Hospira Inc announced that for fiscal 2013, it expects net sales growth to be in a range of 1% to 3% on both a constant-currency and reported basis and adjusted earnings per share (EPS) to be in a range of $2.05 to $2.20, representing growth of 2% to 9%. The Company reported a revenue of $4.092 billion for fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $4.204 billion and EPS of $2.31 for fiscal 2013. 

Company Quote

42.84
-0.16 -0.37%
17 Apr 2014